A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/2002
10/02/2002	EP1244454A2 Use of 2-amino-3,4-dihydro-quinazolines for producing a medicament for treating or preventing diseases caused by ischaemic conditions
10/02/2002	EP1244452A1 Urotensin-ii receptor antagonists
10/02/2002	EP1244451A1 Substituted piperazine and piperidine calcium channel blockers
10/02/2002	EP1244450A1 8-aza-bicyclo[3.2.1]octane nmda/nr2b antagonists
10/02/2002	EP1244443A1 Method for increasing the concentration of ascorbic acid in brain tissues of a subject
10/02/2002	EP1244440A1 Agonists specific for the peripheral cannabinoid receptor
10/02/2002	EP1077964B1 Fumagillol derivatives and processes for preparing the same
10/02/2002	EP1064009B1 Utilization of extracts from iris plants, cimicifuga racemosa and tectorigenin as an estrogen-like organ-selective medicament without uterotropic effects
10/02/2002	EP1047684B1 Substituted alpha,beta-anellated butyrolactones
10/02/2002	EP1047450B1 Ace inhibitor-mmp inhibitor combinations
10/02/2002	EP0996435B1 Amino acid derivatives useful to treat stroke
10/02/2002	EP0984787B1 Use of low-molecular-weight heparins for preventing and treating cerebral edemas
10/02/2002	EP0804196B1 Use of serotonin antagonists (5ht 3) for treating fibromyalgia
10/02/2002	DE10115945A1 Substituierte 2-Carba-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung Substituted 2-carba-3,5-dicyano-4-aryl-6-aminopyridines and their use
10/02/2002	DE10115740A1 Zubereitung für die Restenoseprophylaxe Preparation for the prophylaxis of restenosis
10/02/2002	DE10114138A1 Cdk-inhibitorische Indirubinderivate mit erhöhter Löslichkeit Cdk-inhibitory indirubin derivatives with increased solubility
10/02/2002	DE10112825A1 HESylierung von Wirkstoffen in wässriger Lösung HESylation of drugs in aqueous solution
10/02/2002	CN1372594A OX2 receptor homologs
10/02/2002	CN1372569A Keratinocyte growth factor-2
10/02/2002	CN1372563A Oxathiepino [6,5-b] dihydropyridines, and related compositions and methods
10/02/2002	CN1372559A Naphthyridine derivatives processes for their preparation their use and pharmaceutical compositions comprising them
10/02/2002	CN1372557A Neurotrophin production/secretion promoting agent
10/02/2002	CN1372555A Compositions and therapeutic mehtods involving isoflavones and analogues thereof
10/02/2002	CN1372553A Novel thiazine or pyrazine derivatives
10/02/2002	CN1372547A Aminoalkoxy carbazoles for the treatment of CNS diseases
10/02/2002	CN1372544A 新颖的维生素d类似物 Novel analogues of vitamin d
10/02/2002	CN1372543A new vitamin derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments
10/02/2002	CN1372541A Sulfonyl carboxamide derivatives, method for their production and their use as medicaments
10/02/2002	CN1372475A Combination therapy of angiotension converting enzyme inhibitor and epoxy-steroidal aldosterone anatagonist for treatment of cardiovascular disease
10/02/2002	CN1372474A Methods for preventing or attenuating patthoangiogenic conditions
10/02/2002	CN1372473A Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
10/02/2002	CN1371744A Gingko leaf slow-releasing table and preparation process thereof
10/02/2002	CN1371740A Chinese medicine injection for treating acute cerebral hemorrhage and preparation method thereof
10/02/2002	CN1371728A Powder medicine for promoting blood circulation and removing blood stasis
10/02/2002	CN1371727A Gastrodia tuber multi-function health care tea
10/02/2002	CN1371717A Traditional Chinese medicine composition for treating ischemic cardio-verebral vascular disease and peripheral vascular disease
10/02/2002	CN1371710A Chinese patent drug made by using pseudo-ginseng and epimedium as raw material for curing coronary heart disease
10/02/2002	CN1371698A Compound traditional Chinese medicine for preventing and curing apoplexy and preparation method thereof
10/02/2002	CN1091768C Novel benzo-1,3-dioxolyl-and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
10/02/2002	CN1091766C Prenyl transferase inhibitors
10/02/2002	CN1091608C Oral liquid for depressing blood pressure
10/02/2002	CN1091604C Processed ginseng extract having enhanced pharmacological offset and preparation method
10/02/2002	CN1091600C Process for preparing controlled-release tablet of diltiazem hydrochloride
10/02/2002	CN1091593C Solid pharmaceutical composition contg. benzofurnace derivs
10/02/2002	CA2404775A1 Agent for treating disease due to constrictive vascular lesion
10/01/2002	US6459003 Ether compounds
10/01/2002	US6458963 Process for preparing eprosartan using regioselective protection of 2,4-disubstituted-imidazole intermediates
10/01/2002	US6458951 For treatment of male erectile dysfunction, female sexual dysfunction
10/01/2002	US6458851 Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications
10/01/2002	US6458850 Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications
10/01/2002	US6458846 Ion channel modulating agents
10/01/2002	US6458845 Macrophage scavenger receptor antagonists
10/01/2002	US6458837 Lipophilic diesters of chelating agents
10/01/2002	US6458831 Matairesinol and (-)- wikstromol phenols together with or associated with therapeutically acceptable additives are useful as antioxidants and as free radical scavengers
10/01/2002	US6458827 Adjustent of conformation equilibrium; active materials
10/01/2002	US6458822 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
10/01/2002	US6458819 Thiazolium compounds and treatments of disorders associated with protein aging
10/01/2002	US6458814 Vitronectin receptor antagonists and are useful in the treatment of osteoporosis: treatment of inflammation, cancer and cardiovascular disorders, such as atherosclerosis and restenosis, and diseases wherein bone resorption is a factor,
10/01/2002	US6458813 2-cyclohexyloxy-5-(2-chlorophenylcarbonylamino)pyridine, for example; treating inflammation, pain, diabetes, cancer
10/01/2002	US6458810 Pharmaceutically active isoindoline derivatives
10/01/2002	US6458805 Antagonists; especially sodium salts
10/01/2002	US6458801 Benzofurane derivatives, preparation method, use as medicines and pharmaceutical compositions containing same
10/01/2002	US6458796 Method of treating cardiovascular disorders, thromboembolic disorders and ischaemias, and urogenital system disorders, comprising administering to mammals
10/01/2002	US6458794 Potassium channel inhibitors
10/01/2002	US6458787 Novel pyrrolidine compounds that are potent and selective inhibitors of pde4, as well as methods of making the same, are disclosed. use of the compounds in the treatment of inflammatory diseases and other diseases involving elevated
10/01/2002	US6458775 NAALADase inhibitors useful as pharmaceutical compounds and compositions
10/01/2002	US6458760 Comprising administering to said patient a therapeutically effective amount of a compound which is a specific inhibitor of either cathepsin b or cathepsin l, but which is not as effective inhibitor of calpain
10/01/2002	US6458586 Replication of defective vectors with mutations and deletions; gene therapy, vaccines, genetic engineering
10/01/2002	US6458392 Using coffee bean extract
10/01/2002	US6458383 Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
10/01/2002	US6458361 Soaking in water, heating beyond boiling point, stirring, filtering
10/01/2002	US6458353 Anti-CCR2 antibodies and methods of use therefor
10/01/2002	US6458351 Yeast extracts
10/01/2002	US6458338 Amino acid stabilized medicinal aerosol formulations
10/01/2002	CA2248047C Antagonism of endothelin actions
10/01/2002	CA2245857C 1,4-dihydropyridine compounds as bradykinin antagonists
10/01/2002	CA2235943C Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
10/01/2002	CA2228370C Piperazino derivatives as neurokinin antagonists
10/01/2002	CA2210258C Substituted oxazolidine calpain and/or cathepsin b inhibitors
10/01/2002	CA2168113C Therapeutic peptide derivatives
10/01/2002	CA2103546C Modified factor vii
10/01/2002	CA2075358C Multimers of the soluble forms of tnf receptors, their preparation and pharmaceutical compositions containing them
10/01/2002	CA2063926C Imidazopyridine
10/01/2002	CA2059708C Indole derivatives
09/2002
09/30/2002	CA2379791A1 Novel triazine compounds useful as sorbitol dehydrogenase inhibitors
09/26/2002	WO2002075302A1 Method for therapeutically treating a clinically recognized form of cardiopathology in a living mammal
09/26/2002	WO2002074981A2 Assays, methods and means relating to hypoxia inducible factor (hif) hydroxylase
09/26/2002	WO2002074980A2 Muteins of hypoxia inducible factor alpha and methods of use thereof
09/26/2002	WO2002074971A1 Flavonoid compound and process for producing the same
09/26/2002	WO2002074945A1 Method for cleaving human growth hormone gh
09/26/2002	WO2002074924A2 Method for measuring serine palmitoyltransferase in mammalian tissue and use thereof
09/26/2002	WO2002074913A2 Nucleic acid-associated proteins
09/26/2002	WO2002074806A2 New interferon beta-like molecules
09/26/2002	WO2002074805A1 Soluble rage protein
09/26/2002	WO2002074792A1 Fo-6979 substances and process for producing the same
09/26/2002	WO2002074782A2 Isolation and purification procedure of vasopeptidase peptide inhibitors
09/26/2002	WO2002074780A1 Chemical compounds
09/26/2002	WO2002074773A1 Imidazo-pyrimidine derivatives as ligands for gaba receptors
09/26/2002	WO2002074772A1 Imidazo-pyrimidine derivatives as ligands for gaba receptors
09/26/2002	WO2002074768A1 Piperazine derivatives, their preparation and uses in therapy (5ht1b receptor activity)

1 ... 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 ... 1595